ZYUS Life Sciences Corporation (CVE:ZYU – Free Report) – Equities research analysts at Stifel Canada issued their FY2024 EPS estimates for shares of ZYUS Life Sciences in a research report issued to clients and investors on Wednesday, March 5th. Stifel Canada analyst J. Keywood forecasts that the company will post earnings per share of ($0.24) for the year. Stifel Canada also issued estimates for ZYUS Life Sciences’ Q4 2024 earnings at ($0.07) EPS.
ZYUS Life Sciences Stock Performance
Featured Articles
- Five stocks we like better than ZYUS Life Sciences
- How to buy stock: A step-by-step guide for beginners
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- What is an Earnings Surprise?
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- CD Calculator: Certificate of Deposit Calculator
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for ZYUS Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZYUS Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
